This site uses third parties to own and optimize your navigation and perform analytical work cookies. If you continue browsing, consider that you accept its use.
You can learn more at our Cookie Policy.


in vitro Disease Models - Phenotypic Assays

Innoprot assay development platform combinens both target-based and phenotypic screening due to their important role to move from in-vitro to in-vivo pharmacology for a high range of disease pathways. It can be directed toward the best detection technology for a given molecular target and screening objective.

Innoprot has developed in vitro models for many diseases, including Alzheimer's Disease, Parkinson's Disease, Amyotrophic Laterial Sclerosis or Ischemic Stroke. These models mimick known pathways associated to each disease and then, based on the disease model, analyze one specific endpoint or a wide variety of morphological analysis as neurite outgrowth, nuclear damage, membrane damage, oxidative stress, mitochondrial damage or functional activity.


© Innoprot 2008 - Cell Based Assays for Drug Discovery Screening - Cookie Policy